Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $36.7500 (1.66%) ($35.5500 - $37.1700) on Fri. Jun. 29, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.77% (three month average) | RSI | 35 | Latest Price | $36.7500(1.66%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -2.8% a day on average for past five trading days. | Weekly Trend | ATRA declines -7.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) ARKG(52%) IBB(51%) IWO(51%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -1.885% in a week (0% probabilities). VXX(-15%) VIXM(-14%) TLT(-14%) UUP(-11%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.885% (StdDev 3.77%) | Hourly BBV | 0 () | Intraday Trend | 1.1% | | | |
|
1 - 5 Day Possible Target | $23.76(-35.35%) | Resistance Level | $43.3 | 5 Day Moving Average | $38.14(-3.64%) | 10 Day Moving Average | $41.33(-11.08%) | 20 Day Moving Average | $43.3(-15.13%) | To recent high | -28.6% | To recent low | 4.6% | Market Cap | $2.731b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |